Motor Neurone Disease is a life-shortening disease affecting 1 in 300 people. There is no known cure.
The MND Translational Accelerator (MNDAcc) is a £6m investment by the Medical Research Council and the National Institute for Health and Care Research to quicken the development of treatments for MND, and the related condition of Frontotemporal dementia (FTD). MNDAcc is part of a national drive to translate new discoveries into treatments, providing infrastructure, facilities, services, and funding for high quality in-human research.
NEWS - Minister welcomes acceleration of MND research
At the launch of the MND Translational Accelerator, Health and Social Care Secretary Steve Barclay said:
“Motor Neurone disease has a devastating impact on people’s lives. That is why I am cutting red tape to accelerate funding for cutting-edge research by leading scientists into finding a cure. This collaboration will help identify new potential treatments for MND – backed by £6 million of government investment as part of our pledged £50 million funding for MND research to help find a cure. I encourage researchers from a range of disciplines to join the scheme and harness the world-leading facilities available at Dementias Platform UK and UK Dementia Research Institute.”
NEWS - Funding applications
The submission date for the 24 projects looking to join the MND Accelerator programme has now passed. All the projects will be reviewed by our Scientific Steering Group. It is expected that between 8 and 12 projects will be funded. We'll be announcing who has been successful in April. There is a lot to be done before those awards are announced. As part of the process we have a period for peer review and rebuttals which will close on 18th March.